Log in to save to my catalogue

Mechanisms of Action for Treatments in??Multiple Sclerosis: Does a Heterogeneous Disease Demand a Mu...

Mechanisms of Action for Treatments in??Multiple Sclerosis: Does a Heterogeneous Disease Demand a Mu...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_19378821

Mechanisms of Action for Treatments in??Multiple Sclerosis: Does a Heterogeneous Disease Demand a Multi-Targeted Therapeutic Approach?

About this item

Full title

Mechanisms of Action for Treatments in??Multiple Sclerosis: Does a Heterogeneous Disease Demand a Multi-Targeted Therapeutic Approach?

Author / Creator

Publisher

New Zealand: Wolters Kluwer Health, Inc

Journal title

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2005-01, Vol.19 (5), p.299-308

Language

English

Formats

Publication information

Publisher

New Zealand: Wolters Kluwer Health, Inc

More information

Scope and Contents

Contents

The etiology of multiple sclerosis (MS) is incompletely understood, and evidence suggests there may be more than one underlying cause in this disorder. Furthermore, this complex and heterogeneous autoimmune disease shows a high degree of clinical variability between patients. Therefore, in the absence of a single therapeutic target for MS, it is di...

Alternative Titles

Full title

Mechanisms of Action for Treatments in??Multiple Sclerosis: Does a Heterogeneous Disease Demand a Multi-Targeted Therapeutic Approach?

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_19378821

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_19378821

Other Identifiers

ISSN

1173-8804

DOI

10.2165/00063030-200519050-00003

How to access this item